scholarly journals Differences in Thrombotic Risk Factors in Black and White Women with Adverse Pregnancy Outcome

2014 ◽  
Vol 133 (1) ◽  
pp. 108-111 ◽  
Author(s):  
Claire S. Philipp ◽  
Ambarina S. Faiz ◽  
Michele G. Beckman ◽  
Althea Grant ◽  
Paula L. Bockenstedt ◽  
...  
2015 ◽  
Vol 43 (6) ◽  
Author(s):  
Katarina Jeremic ◽  
Aleksandar Stefanovic ◽  
Jelena Dotlic ◽  
Jelena Stojnic ◽  
Sasa Kadija ◽  
...  

AbstractThe study aim was to evaluate pregnancy outcomes in patients with antiphospholipid syndrome (APS) and to determine which clinical parameters present risk factors for adverse pregnancy outcomes in these patients.The study included 55 patients with APS treated at the Clinic for Ob/Gyn, Clinical Center of Serbia, from 2006 to 2012. The control group consisted of 55 healthy pregnant women. Data regarding previous pregnancies and conception method were registered. Immunological and laboratory tests were performed. Pregnancy outcomes, including miscarriage, intrauterine fetal death, hypertensive disorders, diabetes mellitus, phlebothrombosis, fetal growth restriction, premature delivery, delivery method, perinatal asphyxia, respiratory distress syndrome, intraventricular hemorrhage, and necrotizing enterocolitis were followed.The premature delivery rate in APS patients was 31.8%, and pregnancy loss was 18.2%. Significantly more patients with APS had thrombocytopenia, pregnancy losses, intrauterine growth restriction, and perinatal asphyxia compared with the control group. More miscarriages, preterm delivery, lower birth weight, preeclampsia, and IgM anticardiolipin antibody levels significantly correlated with adverse pregnancy outcomes. Although rare, respiratory distress syndrome can also worsen neonatal health status. According to ROC analysis, previous miscarriages correctly explained 66.3% of adverse pregnancy outcome cases. We generated four equations of adverse pregnancy outcome risk factors.The most important prognostic factor for pregnancy outcome in APS patients is the number of previous miscarriages. Using appropriate current therapeutic protocol can enable live birth of a healthy newborn in most cases.


Author(s):  
Martina S. Balat ◽  
Saurabh Kumar Sahu

Background: Congenital heart diseases (CHD) is the second leading cause of death in infancy and childhood. So the purpose of this study to know socio-demographic profile and the maternal risk factors affecting CHD, and the role of RBSK in screening with respect to CHD.Methods: A cross-sectional study was conducted during June to October 2016 in Ahmedabad city. Parents of 169 children with CHD who were beneficiaries of RBSK during the previous 3 months were interviewed.Results: The majority of children were in the age group of 0-3 years 49.7% (mean±SD= 4.26±4). Majority of families belonged to the lower middle class IV (41.4%). 44% of mothers had primary education. Mothers with age >30 yrs were 55.6%. Only 30.9% of mothers had taken folic acid during the periconceptional period. Mothers with previous adverse pregnancy outcome were 40.2%. Maternal stress and high blood pressure were present in 33.7% and 24.8% of the mothers respectively. 48% of children were diagnosed through Rashtriya Bal Swasthya Karyakram (RBSK).Conclusions: Lower middle class, lower maternal education, advanced maternal age, low folic acid intake, previous adverse pregnancy outcome, maternal stress and high blood pressure were the leading risk factors for CHD. RBSK is playing important role in screening and diagnosing of patients.


Blood ◽  
2009 ◽  
Vol 114 (22) ◽  
pp. 2982-2982
Author(s):  
Claire S. Philipp ◽  
Ambarina Faiz ◽  
Sheetal Shrimanker ◽  
Michele G Beckman ◽  
Paula L. Bockenstedt ◽  
...  

Abstract Abstract 2982 Poster Board II-958 Pregnancy complications such as recurrent miscarriage, intrauterine growth restriction (IUGR), and preeclampsia are common and have been associated with thrombophilia. However racial differences are poorly described for this population. The objective of this study was to determine racial differences in unexplained adverse pregnancy outcome among women obtaining care in the CDC Thrombosis and Hemostasis Centers Research and Prevention Network. Uniform data were prospectively collected from August 2003 to March 2009 in consenting women with a history of adverse pregnancy outcome obtaining care at Network Centers for pre-pregnancy, pregnancy, or postpartum consultation and/or management. Data from 407 women (mean age 38.5 ±12 yrs), including 326 white women (mean age 39.4 ± 12 yrs), and 60 black women (mean age 33.9 ± 11 yrs) were analyzed. Black women had significantly more second trimester pregnancy losses compared to white women (35% vs 22%, p=0.03) but the proportions of 1st trimester losses, 3rd trimester losses, IUGR, prematurity, abruption, and preeclampsia were not significantly different. The risk of thrombophilia differed by race, with Factor V Leiden mutation more common in white women compared to black women (19% vs 3%, p=0.002). Protein S deficiency was more common in black women compared to white women overall (15% vs 5%, p=0.006) and in the subgroup of non-pregnant women (14% vs 5%, p=0.04). There was no significant difference in the proportion of white and black women with antiphospholipid antibodies. Among 285 women evaluated when non-pregnant, body mass index (BMI) ≥ 25 was more frequent in black women (83%) compared to white women (63%) (p=0.04). Overall, black women had a significantly higher proportion with hypertension (27% vs 11%, p=0.002) and sickle cell disease (7% vs 0,%, p< 0.001). There was no significant racial difference in history of pregnancy associated, provoked, or idiopathic venous thromboembolism (VTE). A family history of thrombophilia (6% vs 0%, p=0.05), VTE (22% vs 7%, p=0.005), myocardial infarction (MI) or stroke (12% vs 0%, p=0.0042) was significantly more common in white women compared to black women (overall 32% vs 8%, p<0.0002). This study demonstrates that comorbidities including hypertension, sickle cell disease and BMI≥25 are more prevalent in black women with adverse pregnancy outcomes whereas white women have a higher prevalence of Factor V Leiden mutation, and positive family history of thrombophilia, VTE, MI, and stroke. Disclosures: No relevant conflicts of interest to declare.


Medicine ◽  
2020 ◽  
Vol 99 (45) ◽  
pp. e23094
Author(s):  
Donghua Xie ◽  
Yueyun Xiang ◽  
Aihua Wang ◽  
Lili Xiong ◽  
Fanjuan Kong ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document